In AD-induced Swiss albino mice, gefitinib attenuates hippocampal-dependent memory impairment as assessed by the Morris water maze (MWM) test and reduces acetylcholinesterase (AChE) activity (Dhamodharan et al., 2022). This evidence concerns the gene ACHE and Alzheimer disease.